While we demonstrated here that patients with GPA and healthy individuals have a similar capacity for B cell IL10 production after TLR9 activation, differences in the in vivo environment could result in different B cell cytokine production profiles. This evidence concerns the gene TLR9 and granulomatosis with polyangiitis.